FDA Expands Sevabertinib Indication for Nonsquamous Non-Small Cell Lung Cancer
FDA Expands Sevabertinib Indication for Nonsquamous Non-Small Cell Lung Cancer Oncology News Central
FDA Expands Sevabertinib Indication for Nonsquamous Non-Small Cell Lung Cancer Oncology News Central
New Huntsman cancer campus takes shape in Vineyard Lehi Free Press
Blood-Based OPG Testing May Detect and Track Bone Metastases in Medullary Thyroid Cancer Clinical Lab Products
5 Years of Prostate Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients Cure Today
Guardant360 CDx Test Approved for Early, ‘Serial’ Use in Breast Cancer Inside Precision Medicine
FDA Approves Camizestrant for ESR-1 Mutated Breast Cancer Breast Cancer Research Foundation | BCRF
Researchers at The University of Texas MD Anderson Cancer Center have uncovered a possible reason why metastatic medullary thyroid cancer causes abnormal bone growth, pointing to a new opportunity to detect and monitor bone metastases in patients.
Study shows how the microbiome shapes lung cancer immunotherapy outcomes news-medical.net
There is no "one-size-fits-all" treatment for patients living with cancer. Cancer occurs when normal cells in the body genetically mutate and transform into abnormal cells that divide uncontrollably.
Mayo Clinic researchers have identified a potential new approach to treating glioblastoma that could help the immune system fight the aggressive brain cancer while improving the effectiveness of existing chemotherapy.
Ученые подтвердили связь между употреблением очень горячих напитков и раком пищевода. Насколько велик риск? news.zerkalo.io
Can Pancreatic Cancer Be Detected Early? Symptoms, Biomarkers, and New Tests Oncodaily
Naples Takes Center Stage in Cancer Research Il Mattino
Израильские ученые разработали анализ крови за 60 долларов для выявления рака легких с точностью более 90 процентов Лехаим